Coagulopathy as a result of factor V inhibitor after exposure to bovine topical thrombin

Journal of Vascular Surgery

Volumn 35, Issue 2, 2002, Pages 400-402

  Neschis, David G ^a,b,c   Heyman, Meyer R ^a,b   Cheanvechai, Vasana ^a,b   Benjamin, Marshall E ^a,b   Flinn, William R ^a,b  

^a University of Maryland School of Medicine ^*

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FACTOR V INHIBITOR; PROTEIN INHIBITOR; THROMBIN; UNCLASSIFIED DRUG; ANTIBODY; BLOOD CLOTTING FACTOR 5;

AGED; ANAMNESIS; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; PROTHROMBIN TIME; ANIMAL; CATTLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; IMMUNOLOGY; POSTOPERATIVE COMPLICATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; ANIMALS; ANTIBODIES; BLOOD COAGULATION DISORDERS; CATTLE; FACTOR V; FEMALE; HUMANS; POSTOPERATIVE COMPLICATIONS; THROMBIN;

EID: 0036482878     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.118587     Document Type: Article

References (9)

1. Shortell CK, Illig, KA, Ouriel KO. Perioperative hemorrhage. In: Rutherford RB, ed. Vascular surgery. Vol 1. Philadelphia: WB Saunders Company; 2000. p. 666-88.
2. Ferguson JH, Johnson CL Jr, Howell DA. A circulating inhibitor (anti-AcG) specific for the labile factor V of the blood coagulation mechanism. Blood 1958;13:382.
3. Zehnder JL, Leung LL. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood 1990;76:2011-6.
4. Ortel TL, Mercer MC, Thames EH, et al. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001;33:88-96.
5. Flaherty MJ, Henderson R, Wener MH. Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery. Ann Intern Med 1989;111:631-4.
6. Banninger H, Hardegger T, Tobler A, et al. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 1993;85:528-32.
7. Berruyer M, Amiral J, Ffrench P, et al. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg 1993;105:892-7.
8. Zumberg MS, Waples JM, Kao KJ, Lottenberg R. Management of a patient with a mechanical aortic valve and antibodies to both thrombin and factor V after repeat exposure to fibrin sealant. Am J Hematol 2000;64:59-63.
9. Ortel TL. Clinical and laboratory manifestations of anti-factor V antibodies. J Lab Clin Med 1999;133:326-34.